Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil
- 30 September 2004
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 50 (1), 25-32
- https://doi.org/10.1016/j.diagmicrobio.2004.04.009
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazoleMicrobiology, 2000
- Recent Developments in Molecular Genetics of Candida AlbicansAnnual Review of Microbiology, 2000
- Identification of a Mating Type-Like Locus in the Asexual Pathogenic Yeast Candida albicansScience, 1999
- Aspergillus fumigatusand AspergillosisClinical Microbiology Reviews, 1999
- Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical Candida albicans StrainsAntimicrobial Agents and Chemotherapy, 1998
- Antifungals: mechanism of action and resistance, established and novel drugsCurrent Opinion in Microbiology, 1998
- In VivoCharacterization of the Drug Resistance Profile of the Major ABC Transporters and Other Components of the Yeast Pleiotropic Drug Resistance NetworkMicrobial Drug Resistance, 1998
- Gapped BLAST and PSI-BLAST: a new generation of protein database search programsNucleic Acids Research, 1997
- The Mutation T315A in Candida albicans Sterol 14α-Demethylase Causes Reduced Enzyme Activity and Fluconazole Resistance through Reduced AffinityPublished by Elsevier BV ,1997
- Nucleotide sequence of cytochrome P450 LIAI (lanosterol 14α-demethylase) fromCandida albicansNucleic Acids Research, 1989